Scrip Regulatory Affairs
The New EU Data Protection Regulation: What will the Impact be on the Life Sciences Industry?
March 2012
The EU Data Protection Regulation proposed by the European Commission in January will - if adopted in its current form - require pharmaceutical and medical device companies to adopt a new approach to data processing and data protection.
This article was published in the March 2012 issue of Scrip Regulatory Affairs.
Contacts
Capabilities
Suggested News & Insights
UK Operational Incident and Third-Party Reporting Rules: What Firms Should Do NowApril 16, 2026Chambers 2026 Global Practice Guide for CybersecurityApril 15, 2026Regulatory Update: National Association of Insurance Commissioners Spring 2026 National MeetingApril 14, 2026India’s Digital Regulation in Focus: Implications of the 2026 United States Trade Representative Report for American CompaniesApril 13, 2026Seventh Circuit Limits Potential Damages Under BIPA, Holds 2024 Amendment Applies RetroactivelyApril 8, 2026Chambers 2026 Global Practice Guide for CybersecurityApril 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
